CVS Health Corp.

  • Market Cap: Large Cap
  • Industry: Retailing
  • ISIN: US1266501006
USD
76.75
1.75 (2.33%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
98,942.00
94,609.00
97,504.00
95,409.00
91,324.00
88,455.00
93,965.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
98,942.00
94,609.00
97,504.00
95,409.00
91,324.00
88,455.00
93,965.00
Raw Material Cost
85,322.00
80,192.00
84,811.00
82,870.00
77,851.00
75,876.00
79,937.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
31,317.00
29,135.00
29,543.00
29,922.00
27,853.00
27,803.00
22,518.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
768.00
779.00
754.00
746.00
727.00
710.00
684.00
Selling and Distribution Expenses
10,306.00
10,343.00
10,481.00
10,516.00
10,236.00
10,130.00
10,310.00
Other Expenses
-3,208.50
-2,991.40
-3,029.70
-3,066.80
-2,858.00
-2,851.30
-2,320.20
Total Expenditure (Excl Depreciation)
95,628.00
90,535.00
95,292.00
93,386.00
88,087.00
86,006.00
90,247.00
Operating Profit (PBDIT) excl Other Income
3314
4074
2212
2023
3237
2449
3718
Other Income
7.00
1.00
227.00
38.00
-71.00
1.00
-136.00
Operating Profit (PBDIT)
4,492.00
5,229.00
3,586.00
3,222.00
4,317.00
3,588.00
4,716.00
Interest
768.00
779.00
754.00
746.00
727.00
710.00
684.00
Exceptional Items
-906.00
-679.00
441.00
-1,210.00
-102.00
-160.00
-193.00
Gross Profit (PBDT)
13,620.00
14,417.00
12,693.00
12,539.00
13,473.00
12,579.00
14,028.00
Depreciation
1,171.00
1,154.00
1,147.00
1,161.00
1,151.00
1,138.00
1,134.00
Profit Before Tax
1,647.00
2,617.00
2,126.00
105.00
2,337.00
1,580.00
2,705.00
Tax
634.00
835.00
503.00
34.00
569.00
456.00
658.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
1,021.00
1,779.00
1,644.00
87.00
1,770.00
1,113.00
2,046.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
1,021.00
1,779.00
1,644.00
87.00
1,770.00
1,113.00
2,046.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-8.00
3.00
-21.00
-16.00
-2.00
11.00
1.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
1,013.00
1,782.00
1,623.00
71.00
1,768.00
1,124.00
2,047.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Reserves
77,379.00
76,929.00
75,560.00
74,944.00
74,930.00
73,968.00
76,461.00
Earnings per share (EPS)
0.8
1.41
1.3
0.07
1.41
0.88
1.58
Diluted Earnings per share
0.8
1.41
1.3
0.07
1.41
0.88
1.58
Operating Profit Margin (Excl OI)
3.35%
4.31%
2.27%
2.12%
3.54%
2.77%
3.96%
Gross Profit Margin
2.85%
3.99%
3.36%
1.33%
3.82%
3.07%
4.09%
PAT Margin
1.03%
1.88%
1.69%
0.09%
1.94%
1.26%
2.18%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Jun 2025 is 8.34% vs 2.59% in Jun 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Jun 2025 is -42.70% vs -7.63% in Jun 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2025 is 2.21% vs -13.77% in Jun 2024

stock-summary

Interest

YoY Growth in quarter ended Jun 2025 is 5.64% vs 2.54% in Jun 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024

Compare Quarterly Results Of CVS Health Corp. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
98,942.00
5,646.08
93,295.92
1,652.40%
Other Operating Income
0.00
0.00
0.00
Total Operating income
98,942.00
5,646.08
93,295.92
1,652.40%
Raw Material Cost
85,322.00
4,550.48
80,771.52
1,775.01%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
31,317.00
0.00
31,317.00
Power Cost
0
0
0.00
Manufacturing Expenses
768.00
72.66
695.34
956.98%
Selling and Distribution Expenses
10,306.00
1,167.72
9,138.28
782.57%
Other Expenses
-3,208.50
-7.27
-3,201.23
-44,033.43%
Total Expenditure (Excl Depreciation)
95,628.00
5,718.20
89,909.80
1,572.34%
Operating Profit (PBDIT) excl Other Income
3,314.00
-72.12
3,386.12
4,695.12%
Other Income
7.00
24.09
-17.09
-70.94%
Operating Profit (PBDIT)
4,492.00
21.00
4,471.00
21,290.48%
Interest
768.00
72.66
695.34
956.98%
Exceptional Items
-906.00
-886.76
-19.24
-2.17%
Gross Profit (PBDT)
13,620.00
1,095.60
12,524.40
1,143.15%
Depreciation
1,171.00
69.03
1,101.97
1,596.36%
Profit Before Tax
1,647.00
-1,007.46
2,654.46
263.48%
Tax
634.00
2.34
631.66
26,994.02%
Provisions and contingencies
0
0.00
0.00
Profit After Tax
1,021.00
-1,009.79
2,030.79
201.11%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
1,021.00
-1,009.79
2,030.79
201.11%
Share in Profit of Associates
0
0.00
0.00
Minority Interest
-8.00
0.00
-8.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
1,013.00
-1,009.79
2,022.79
200.32%
Equity Capital
0
0
0.00
Face Value
0.01
1.00
0.00
Reserves
77,379.00
-1,908.18
79,287.18
4,155.12%
Earnings per share (EPS)
0.80
-18.26
19.06
104.38%
Diluted Earnings per share
0.80
-18.26
19.06
104.38%
Operating Profit Margin (Excl OI)
3.35%
-1.28%
0.00
4.63%
Gross Profit Margin
2.85%
-16.62%
0.00
19.47%
PAT Margin
1.03%
-17.88%
0.00
18.91%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 9,894.20 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 4.58% vs -2.97% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 8.34% vs 2.59% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 101.30 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -43.15% vs 9.80% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -42.70% vs -7.63% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 448.50 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -14.21% vs 55.64% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 2.21% vs -13.77% in Jun 2024

Quarterly - Interest
Interest 76.80 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -1.41% vs 3.32% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 5.64% vs 2.54% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 3.35%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024